Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TG level at 0.362 mmol/Kg, IG administered for 1 week and measured on day 7
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TC level at 0.362 mmol/Kg, IG administered for 1 week and measured on day 7
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum MDA level at 0.362 mmol/Kg, IG administered for 1 week and measured on day 7
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TG level at 0.121 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TG level at 0.362 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TG level at 1.086 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TC level at 0.121 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TC level at 0.362 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TC level at 1.086 mmol/Kg, IG administered for 1 week and measured on day 7 relative to control
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TG level administered IG for 1 week and measured on day 7
Hypolipidemic activity in KM mouse model of Triton WR 1339-induced hyperlipidemia assessed as reduction in serum TC level administered IG for 1 week and measured on day 7 relative to control